KURA icon

Kura Oncology
KURA

Overview Fund Activity

30 hedge funds and large institutions have $58.2M invested in Kura Oncology in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
30
Holders Change
+2
Holders Change %
+7.14%
% of All Funds
0.75%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
7
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
1
Morgan Stanley
New York
$922K
2
JPMPWA
2
J.P. Morgan Private Wealth Advisors
California
$174K
3
Squarepoint
3
Squarepoint
New York
$74K
4
OC
4
Oppenheimer & Co
New York
$64K
5
Deutsche Bank
5
Deutsche Bank
Germany
$50K

Top Sellers

1
BC
1
Birchview Capital
Vermont
$0
2
PHS
2
PFM Health Sciences
California
$11.7M
3
CCP
3
Clough Capital Partners
Massachusetts
$3.9M
4
UBS Group
4
UBS Group
Switzerland
$10K
5
MA
5
MUFG Americas
New York
$3K
Name Holding Trade Value Shares
Change 		Shares
Change %
UBS Group
26
UBS Group
Switzerland
$10K -$10.5K -1,864 -51%
Manulife (Manufacturers Life Insurance)
27
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$5K – – –
MA
28
MUFG Americas
New York
$3K -$3.11K -570 -51%
RFA
29
Reilly Financial Advisors
California
$1K – – –
BC
30
Birchview Capital
Vermont
– -$369K -59,114 Closed
TRCT
31
Tower Research Capital (TRC)
New York
– -$1K -200 Closed
1
2